Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epidemiologic study of fluorouracil-related cardiotoxicity in solid tumors
ChiCTR1800015434Phase 4Completed
- Sponsor
- Sun Yat-sen University Cancer Center
- Start
- Jan 2014
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of fluorouracil and capecitabine in colorectal cancer (CRC), gastric cancer (GC), breast cancer and 2 more (2 arms), sponsored by Sun Yat-sen University Cancer Center. Primary endpoint: Incidence of cardiotoxicity. Started Jan 2014; status: completed.
02
Drugs
fluorouracilcapecitabine
03
Conditions
colorectal cancer (CRC)gastric cancer (GC)breast canceresophageal cancerhead and neck cancer (HNC)
Beyond the preview
Go deeper on ChiCTR1800015434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800015434.